Literature DB >> 28530950

Effects of Buspirone on Agitation Associated With Dementia.

Kenneth M Sakauye1, Cameron J Camp1, Patricia A Ford1.   

Abstract

Ten patients with probable Alzheimer's disease participated in an open-label study of buspirone for agitation. The starting dose of 15 mg/day was increased by 5 mg every week until maximal improvement or 60 mg/day was reached. A significant decrease in agitation scores occurred at an average dose of 35 mg/day.
Copyright © 1993 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2013        PMID： 28530950     DOI： 10.1097/00019442-199300110-00011

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN： 1064-7481            Impact factor:   4.105


  4 in total

1.  Alzheimer's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

Review 2.  Optimal management of anxiety in older patients.

Authors:  K J Weiss
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

Review 3.  Optimal management of behavioural disorders associated with dementia.

Authors:  C A Class; L Schneider; M R Farlow
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 4.271

Review 4.  Management of agitation in nursing home patients.

Authors:  N Billig
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.